Kenneth Janzon
Director Técnico/Científico/I+D en Nordvacc Läkemedel AB .
Fortuna: 439 236 $ al 30/04/2024
Cargos activos de Kenneth Janzon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Kenneth Janzon
Antiguos cargos conocidos de Kenneth Janzon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTERVACC AB | Director/Miembro de la Junta | 01/01/2001 | 14/06/2018 |
| Fundador | 01/01/2001 | 14/06/2018 | |
| Independent Dir/Board Member | 01/01/2001 | - |
Estadísticas
Internacional
| Suecia | 3 |
Operativa
| Director/Board Member | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 2 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Bolsa de valores
- Insiders
- Kenneth Janzon
- Experiencia
